Verzenio Approved for Advanced Breast Cancer

FRIDAY, Sept. 29, 2017 — Verzenio (abemaciclib) has been approved by the U.S. Food and Drug Administration to treat women with certain advanced forms of breast cancer, the most common cancer in the United States.
More than 250,000 women are…
Source: Topamax